Catalyst
Slingshot members are tracking this event:
Sarepta (SRPT) Agrees to Sell Rare Pediatric Disease Priority Review Voucher for $125MM to Unnamed Party
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| SRPT |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 21, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Fda, Rare Pediatric Disease, Priority Review Voucher
